[go: up one dir, main page]

AP2000001835A0 - Agents. - Google Patents

Agents.

Info

Publication number
AP2000001835A0
AP2000001835A0 APAP/P/2000/001835A AP2000001835A AP2000001835A0 AP 2000001835 A0 AP2000001835 A0 AP 2000001835A0 AP 2000001835 A AP2000001835 A AP 2000001835A AP 2000001835 A0 AP2000001835 A0 AP 2000001835A0
Authority
AP
ARIPO
Prior art keywords
agents
partly
interactive
antigene
hybrids
Prior art date
Application number
APAP/P/2000/001835A
Other languages
English (en)
Inventor
Ulrica Sehlstedt
Palok Aich
Jan Olof Einar Bergman
Hans Vallberg
Bengt Norden
Astrid Graslund
Original Assignee
Lundblad Leif J I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundblad Leif J I filed Critical Lundblad Leif J I
Publication of AP2000001835A0 publication Critical patent/AP2000001835A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
APAP/P/2000/001835A 1997-12-17 1998-12-16 Agents. AP2000001835A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704723A SE9704723D0 (sv) 1997-12-17 1997-12-17 Ligands
PCT/SE1998/002340 WO1999030712A1 (fr) 1997-12-17 1998-12-16 Agents

Publications (1)

Publication Number Publication Date
AP2000001835A0 true AP2000001835A0 (en) 2000-06-30

Family

ID=20409439

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2000/001835A AP2000001835A0 (en) 1997-12-17 1998-12-16 Agents.

Country Status (7)

Country Link
EP (1) EP1037638A1 (fr)
JP (1) JP2002508325A (fr)
AP (1) AP2000001835A0 (fr)
AU (1) AU1899099A (fr)
IL (1) IL136525A0 (fr)
SE (1) SE9704723D0 (fr)
WO (1) WO1999030712A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022002898A1 (fr) * 2020-06-29 2022-01-06 Vironova Medical Ab Dérivés de 6h-indolo(2,3-b)quinoxaline utiles en thérapie, en particulier dans une infection virale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner
SE504289C2 (sv) * 1994-06-23 1996-12-23 Leif J I Lundblad Användning av vissa indolo-2,3b-kinoxaliner för framställning av ett läkemedel för inhibering av enzymet HIV-integras
SE504862C2 (sv) * 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler

Also Published As

Publication number Publication date
AU1899099A (en) 1999-07-05
WO1999030712A1 (fr) 1999-06-24
SE9704723D0 (sv) 1997-12-17
JP2002508325A (ja) 2002-03-19
EP1037638A1 (fr) 2000-09-27
IL136525A0 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
DE69835201D1 (en) Neoglycoproteine
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
EP0339842A3 (fr) Dérivés d'oligoribonucléotides et leur utilisation comme agents antiviraux
ZA983055B (en) Fungicidal trifluorophenyl-triazolopyrimidines.
IL114566A0 (en) Compositions containing mucleic acids their preparation and uses
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
EP1222309A4 (fr) Rnase h humaine et compositions nucleotidiques correspondantes
EP2292771A3 (fr) Thérapie à base d'ARNm sens
ATE252639T1 (de) Modifizierter, das dorsalgewebe beeinflussender faktor
IL117848A0 (en) Novel compounds a process for their production and pharmacetical compositions containing same
ATE541576T2 (de) 2'-o,4'-c-methylen bicyclonukleoside
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
WO1991019707A3 (fr) 1-benzopyran-4-ones et 2-amino-1,3-benzoxazine-4-ones antiathero sclerotiques et antithrombotiques
MY114014A (en) Imidazole compounds, compositions and use
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
BG102259A (en) Compostions with controlled paroxetine release
IN2012DE00109A (fr)
WO1994005791A3 (fr) Facteur influant sur la croissance du tissu dorsal et compositions
EP1077218A3 (fr) Substances peptido-mimétiques contenant des sequences RGD et en tant qu'inhibiteurs des integrins
NZ501492A (en) Di-amine and tetra-amine derivatives and pharmaceuticals thereof, useful for treating cardiac arrhythmia
MY132057A (en) Quinoxalinones, a process for their preparation and their use
HUT77933A (hu) Funkcionális terpiridin-fémkomplexek, eljárás előállításukra valamint alkalmazásuk
AP2000001835A0 (en) Agents.
AU2735199A (en) Novel cationic compounds, their use as coupling agents for oxidation dyeing of keratinous fibres, dyeing compositions and dyeing methods
MX9801133A (es) Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion.